Reassessing the Risks and Benefits of COVID-19 Precautions in 2023 | Oncotarget



September 25, 2023

  • Share
  • Oncotarget published this trending editorial on September 22, 2023 in Volume 14, entitled, “Reassessing the risks and benefits of COVID-19 precautions in 2023" by Thomas A. Ollila, Rashida Taher and Prashanth Moku from the Department of Medicine, Alpert Medical School of Brown University, Providence, RI; Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI. DOI - Correspondence to - Thomas A. Ollila - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, COVID, immunosuppression, coronavirus, vaccination, lymphoma About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - X - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Analytical TechniquesCancer ResearchCell Science

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.